February 2010

Some FDA initiatives for improving the process of drug development and approval in the United States.

1) Accelerated approval The accelerated approval program run by FDA allows sponsors to request approval on the basis of alternate findings. Also called surrogate endpoints, these are indirect assessments of disease status, for example, a change in lab results or improvements in symptoms related to the disease. These endpoints can also be used to assess

Some FDA initiatives for improving the process of drug development and approval in the United States. Read More »

FDA fast track program

With its fast track drug development programs, the FDA seeks to facilitate the development of new drugs and speed up their approval process. This is especially true in case of drugs that can provide for unmet medical needs pertaining to debilitating or life-threatening diseases such as cancer. An unmet medical need is said to exist

FDA fast track program Read More »